Moukheibir Catherine sold MLTX
July 3, 2025 · Form 4 insider transaction
Moukheibir Catherine sold 23,500 shares of MoonLake Immunotherapeutics at $48.79 per share, a transaction worth $1.15M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
23,500
Price
$48.79
Total value
$1.15M
InsiderMoukheibir Catherine
RoleDirector
SecurityClass A ordinary shares, par value $0.0001 per share
Transaction codeS: Open-market sale
Transaction dateJuly 3, 2025
Filing dateJuly 7, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $48.59 to $49.01. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.